Bodal Chemicals Ltd
Bodal Chemicals Ltd Q4 FY26 Results & Presentation Highlights: Revenue, Margins & Order Book
Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Bodal Chemicals Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4 FY26 consolidated revenue: Rs. Q4 FY26 EBITDA: Rs.
From Bodal Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4 FY26 consolidated revenue: Rs. 5,906.0 mn, a 30.3% YoY growth from Rs. 4,532.2 mn in Q4 FY25 (Page 10).
- Q4 FY26 standalone revenue from operations: Rs. 5,771.0 mn, a 29.4% YoY increase from Rs. 4,455.3 mn in Q4 FY25 (Page 11).
- Revenue by segments in Q4 FY26 YoY growth: Dye intermediates Rs. 1,936 mn (+21%), Dyestuffs Rs. 1,441 mn (+15%), Basic Chemicals Rs. 632 mn (+239%) (Page 5).
- Production volumes (standalone basis): Basic Chemicals & Chlor Alkali volumes stable or slight increase, no explicit YoY % given; Dyestuff and Dye Intermediate volumes not quantified explicitly for quarter (Page 8).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The presentation mentions a new greenfield expansion under the "Way Forward" section (Page 28), indicating plans for capacity ramp-up and ongoing internal efficiencies.
- No specific capex amount, detailed project status, or exact timelines are provided in the text of the presentation.
- The "Integrated Business Model" section (Page 25) highlights investment in well-equipped production facilities and continuous R&D but does not quantify capex.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Bodal Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹588 Cr, net profit ₹32 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bodal Chemicals Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Chemfab Alkalis Ltd (Q4 FY26)
Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key investor presentation takeaways from Chemfab Alkalis Ltd's Q4 FY26 investor presenta
- Sudarshan Pharma Industries Ltd (Q4 FY26)
Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key investor presentation takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 investor pr
- Innovassynth Technologies (India) Ltd (Q4 FY26)
Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key investor presentation takeaw
- Jubilant Agri & Consumer Products Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations: INR 4,852 MN, up 22% YoY from INR 3,983 MN in Q4 FY25 (Page 19) . Key investor presentation takeaways from Jubilant Agri & Cons
Frequently Asked Questions
What were Bodal Chemicals Ltd Q4 FY26 results?
Q4 FY26 consolidated revenue: Rs. Q4 FY26 EBITDA: Rs.
What is Bodal Chemicals Ltd share price analysis?
Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bodal Chemicals Ltd planning capital expenditure?
The presentation mentions a new greenfield expansion under the "Way Forward" section (Page 28), indicating plans for capacity ramp-up and ongoing internal efficiencies.
Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.